
LIS Technologies Inc. Files for IPO of 3.1M Shares
LIS Technologies Inc. has filed an amended S-1 registration statement for its initial public offering (IPO) of 3,100,000 shares of common stock, with an anticipated price range of $5.00 to $7.00 per share. The company is an early-stage uranium enrichment firm focused on developing patented laser-based technologies, including its proprietary CRISLA process, for the nuclear energy industry. LIS Technologies has received a radiological material license from the State of Tennessee and NRC approval for its Standard Practice Procedures Plan for its Oak Ridge Test Demonstration Facility, with experiments expected to begin by year-end 2026. The company has not yet generated revenue and has accumulated significant net losses since its inception. Key executives, including the CEO and President, have indicated interest in purchasing shares in the offering.
Key Highlights
- LIS Technologies Inc. files S-1 for IPO of 3,100,000 shares of common stock.
- Anticipated IPO price range is $5.00 to $7.00 per share.
- Company is developing patented laser-based uranium enrichment technology (CRISLA process).
- Received radiological material license from Tennessee and NRC SPPP approval for Oak Ridge facility.
- Experiments with UF6 delivery expected to commence before the end of 2026.
- Has not generated revenue and has accumulated net losses of $65,418,743 as of July 31, 2026.
- CEO and President intend to purchase shares in the offering.
- Seeking listing on the Nasdaq Capital Market under the symbol 'LIS'.
Price Impact
More from LIS